Knee pain breakthrough? PRP and stem cells face off in new trial
NCT ID NCT06893250
First seen Jun 20, 2026 · Last updated Jun 20, 2026
Summary
This study tests whether injections of platelet-rich plasma (PRP) or stem cells from belly fat can help people with knee osteoarthritis. 160 adults aged 40-70 with mild to moderate knee arthritis will be randomly assigned to get PRP, stem cells, both, or a placebo. Researchers will track pain, function, and MRI changes over two years to see which treatment works best.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS, KNEE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital in Northern Norway
Tromsø, Tromsø, 9038, Norway
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Platelet-rich plasma (PRP) and/or adipose tissue stem cells
What this could lead to
If successful, this could point toward a more effective, non-surgical treatment for knee osteoarthritis that reduces pain and improves function.
What could go wrong
This is a mid-stage trial with only 160 participants. It compares several treatments, so it may not clearly show which is best. Also, results may not apply to all patients with knee osteoarthritis.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.